# Novartis Venture Fund's Biotech Investments: 39 Startups in Its Portfolio (2026) > The 39 Biotech startups Novartis Venture Fund has backed, by stage: $3.3B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/novartis-venture-fund-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series B 15 - [NovImmune](https://millionrounds.com/company/novimmune) - [Aeglea BioTherapeutics](https://millionrounds.com/company/aeglea-biotherapeutics) - [Galera Therapeutics](https://millionrounds.com/company/galera-therapeutics) - [*CT* Capstan Therapeutics](https://millionrounds.com/company/capstan-therapeutics) - [Sidewinder Therapeutics](https://millionrounds.com/company/sidewinder-therapeutics) - [Bicycle Therapeutics](https://millionrounds.com/company/bicycle-therapeutics) - [EpiBiologics](https://millionrounds.com/company/epibiologics) - [GenSight Biologics](https://millionrounds.com/company/gensight-biologics) - [TScan Therapeutics](https://millionrounds.com/company/tscan-therapeutics) - [Ra Pharmaceuticals](https://millionrounds.com/company/ra-pharmaceuticals) - [*E* ESBATech](https://millionrounds.com/company/esbatech) - [ImaginAb](https://millionrounds.com/company/imaginab) - [Epsilogen Ltd.](https://millionrounds.com/company/epsilogen-ltd) - [Cequent Pharmaceuticals](https://millionrounds.com/company/cequent-pharmaceuticals) - [*AT* Anchor Therapeutics](https://millionrounds.com/company/anchor-therapeutics) ## Series A 10 - [AstronauTx](https://millionrounds.com/company/astronautx) - [Vivet Therapeutics](https://millionrounds.com/company/vivet-therapeutics) - [*E* Expansion](https://millionrounds.com/company/expansion) - [Renovacor](https://millionrounds.com/company/renovacor) - [*I* Immunitas](https://millionrounds.com/company/immunitas) - [Quartet Medicine](https://millionrounds.com/company/quartet-medicine) - [Immune Targeting Systems](https://millionrounds.com/company/immune-targeting-systems) - [Forendo Pharma](https://millionrounds.com/company/forendo-pharma) - [*VT* Viron Therapeutics](https://millionrounds.com/company/viron-therapeutics) - [Lemonaid Health](https://millionrounds.com/company/lemonaid-health) ## Series C and later 10 - [FORMA Therapeutics](https://millionrounds.com/company/forma-therapeutics) - [*F* F2G](https://millionrounds.com/company/f2g) - [*AG* Atlas Genetics](https://millionrounds.com/company/atlas-genetics) - [FORE Biotherapeutics](https://millionrounds.com/company/fore-biotherapeutics) - [Effector Therapeutics](https://millionrounds.com/company/effector-therapeutics) - [*SS* Seventh Sense Biosystems](https://millionrounds.com/company/seventh-sense-biosystems) - [*RM* ROX Medical](https://millionrounds.com/company/rox-medical) - [*TT* TorreyPines Therapeutics](https://millionrounds.com/company/torreypines-therapeutics) - [*O* Oxagen](https://millionrounds.com/company/oxagen) - [*CB* Covalys Biosciences](https://millionrounds.com/company/covalys-biosciences) ## Stage not reported 4 - [Celladon](https://millionrounds.com/company/celladon) - [*A* Anokion](https://millionrounds.com/company/anokion) - [*LP* LigoCyte Pharmaceuticals](https://millionrounds.com/company/ligocyte-pharmaceuticals) - [*NP* NeuroGenetic Pharmaceuticals](https://millionrounds.com/company/neurogenetic-pharmaceuticals) ## Segment by segment ### Series B 15 startups · $1.8B raised - [**NovImmune**](https://millionrounds.com/company/novimmune) NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders. Switzerland $352M - [**Aeglea BioTherapeutics**](https://millionrounds.com/company/aeglea-biotherapeutics) Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases. United States $266M - [**Galera Therapeutics**](https://millionrounds.com/company/galera-therapeutics) Galera Therapeutics develops therapeutic agents for preventing damage to normal tissues during the radiation treatment of cancer. United States $219M - [*CT* **Capstan Therapeutics**](https://millionrounds.com/company/capstan-therapeutics) Capstan Therapeutics is advancing cell engineering to develop therapeutics for a broad range of diseases. United States $175M - [**Sidewinder Therapeutics**](https://millionrounds.com/company/sidewinder-therapeutics) Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases. United States $137M - [**Bicycle Therapeutics**](https://millionrounds.com/company/bicycle-therapeutics) Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics. United Kingdom $110M - [**EpiBiologics**](https://millionrounds.com/company/epibiologics) EpiBiologics is a biotechnology company based in San Mateo, California, founded in 2022. United States $107M - [**GenSight Biologics**](https://millionrounds.com/company/gensight-biologics) GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases. France $80M ### Series A 10 startups · $449M raised - [**AstronauTx**](https://millionrounds.com/company/astronautx) AstronauTx Ltd. United Kingdom $124M - [**Vivet Therapeutics**](https://millionrounds.com/company/vivet-therapeutics) Vivet Therapeutics is a biotechnology company developing gene therapy treatments for orphan diseases. France $96M - [*E* **Expansion**](https://millionrounds.com/company/expansion) United States $55M - [**Renovacor**](https://millionrounds.com/company/renovacor) No mercado desde 2009, a Renovacor Tintas se diferencia pela fabricação de tintas e revestimentos acrílicos de qualidade que conta United States $41M - [*I* **Immunitas**](https://millionrounds.com/company/immunitas) United States $39M - [**Quartet Medicine**](https://millionrounds.com/company/quartet-medicine) Quartet Medicine is a private, biotechnology company focused on discovering and developing novel treatments for chronic pain and i United Kingdom $23M - [**Immune Targeting Systems**](https://millionrounds.com/company/immune-targeting-systems) Immune Targeting Systems develops synthetic vaccines for mutating viruses, improving the quality of life for those infected by viruses. United Kingdom $20M - [**Forendo Pharma**](https://millionrounds.com/company/forendo-pharma) Forendo Pharma is a developer of novel drugs intended for the treatment of urological and other endocrinological diseases. Finland $20M ### Series C and later 10 startups · $761M raised - [**FORMA Therapeutics**](https://millionrounds.com/company/forma-therapeutics) FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines. United States $143M - [*F* **F2G**](https://millionrounds.com/company/f2g) United Kingdom $136M - [*AG* **Atlas Genetics**](https://millionrounds.com/company/atlas-genetics) United Kingdom $111M - [**FORE Biotherapeutics**](https://millionrounds.com/company/fore-biotherapeutics) Fore Biotherapeutics is a clinical-stage precision oncology company based in Philadelphia, PA. United States $108M - [**Effector Therapeutics**](https://millionrounds.com/company/effector-therapeutics) Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics. United States $99M - [*SS* **Seventh Sense Biosystems**](https://millionrounds.com/company/seventh-sense-biosystems) United States $52M - [*RM* **ROX Medical**](https://millionrounds.com/company/rox-medical) United States $50M - [*TT* **TorreyPines Therapeutics**](https://millionrounds.com/company/torreypines-therapeutics) TorreyPines Therapeutics engages in the discovery and development of small molecule compounds in the United States. - $35M ### Stage not reported 4 startups · $333M raised - [**Celladon**](https://millionrounds.com/company/celladon) Celladon is a biotechnology company developing molecular therapies for the treatment of heart failure. United States $172M - [*A* **Anokion**](https://millionrounds.com/company/anokion) Switzerland $75M - [*LP* **LigoCyte Pharmaceuticals**](https://millionrounds.com/company/ligocyte-pharmaceuticals) LigoCyte Pharmaceuticals is focused on developing vaccines and monoclonal antibodies for gastrointestinal and respiratory indications. United States $72M - [*NP* **NeuroGenetic Pharmaceuticals**](https://millionrounds.com/company/neurogenetic-pharmaceuticals) Neurogenetic Pharmaceuticals is engaged in the R&D of therapeutics for neurodegenerative disorders such as Alzheimer’s disease. United States $14M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Novartis Venture Fund as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Co-investors **Who invests with Novartis Venture Fund** 52 co-investors](https://millionrounds.com/portfolio-maps/novartis-venture-fund-co-investors)[Investments abroad **Novartis Venture Fund's investments in the United States** 27 startups · $2.2B](https://millionrounds.com/portfolio-maps/novartis-venture-fund-investments-united-states)[Sector portfolio **M Ventures' AI portfolio** 28 startups · $593M](https://millionrounds.com/portfolio-maps/m-ventures-ai-portfolio)[Sector portfolio **Roche Venture Fund's Biotech portfolio** 11 startups · $1.2B](https://millionrounds.com/portfolio-maps/roche-venture-fund-biotech-portfolio)[Sector portfolio **Y Combinator's AI portfolio** 1,143 startups · $44B](https://millionrounds.com/portfolio-maps/y-combinator-ai-portfolio)[Sector portfolio **Y Combinator's Fintech portfolio** 338 startups · $24B](https://millionrounds.com/portfolio-maps/y-combinator-fintech-portfolio) ## Raising from investors like Novartis Venture Fund? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)